Tenofovir alafenamide in blocking mother-to-child transmission of hepatitis B virus: a multi-center, prospective study.

Guorong HanGuanlun ZhouTong SunXiucui LuoJinxia XuChao ChenWen XuSu'e JiangChenxu Wang

Published in: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians (2022)

TAF therapy initiated during the second trimester was effective in preventing MTCT with no safety concerns for mothers and infants (ClinicalTrials.gov number, NCT04065230).

Keyphrases

hepatitis b virus
liver failure
mental health
gestational age
pregnancy outcomes
pregnant women
mesenchymal stem cells
cell therapy